These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1490193)
1. [Effect of mutations in genes of Venezuelan equine encephalomyelitis virus structural proteins on its attenuation]. Frolov IV; Agapov EV; Kolykhalov AA; Netesov SV; Sandakhchiev LS Dokl Akad Nauk; 1992; 326(6):1078-82. PubMed ID: 1490193 [No Abstract] [Full Text] [Related]
2. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV. Phillpotts RJ; Lescott TL; Jacobs SC Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667 [TBL] [Abstract][Full Text] [Related]
3. [An experimental evaluation of the attenuated strain 15 of the Venezuelan equine encephalomyelitis virus]. Lukin EP; Selivanenko GM; Chernikova NK; Pshenichnov VA Vopr Virusol; 1991; 36(3):243-5. PubMed ID: 1891883 [No Abstract] [Full Text] [Related]
4. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087 [TBL] [Abstract][Full Text] [Related]
5. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus. Aronson JF; Grieder FB; Davis NL; Charles PC; Knott T; Brown K; Johnston RE Virology; 2000 Apr; 270(1):111-23. PubMed ID: 10772984 [TBL] [Abstract][Full Text] [Related]
7. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models. Pratt WD; Davis NL; Johnston RE; Smith JF Vaccine; 2003 Sep; 21(25-26):3854-62. PubMed ID: 12922119 [TBL] [Abstract][Full Text] [Related]
8. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of the amino acid sequence of structural proteins from attenuated and pathogenic strains of the Venezuelan equine encephalomyelitis virus]. Frolov IV; Kolykhalov AA; Volchakov VE; Netesov SV; Sandakhchiev LS Dokl Akad Nauk SSSR; 1991; 318(6):1488-91. PubMed ID: 1914828 [No Abstract] [Full Text] [Related]
10. Molecular determinants of alphavirus neurovirulence: nucleotide and deduced protein sequence changes during attenuation of Venezuelan equine encephalitis virus. Johnson BJ; Kinney RM; Kost CL; Trent DW J Gen Virol; 1986 Sep; 67 ( Pt 9)():1951-60. PubMed ID: 3755750 [TBL] [Abstract][Full Text] [Related]
11. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Davis NL; Brown KW; Greenwald GF; Zajac AJ; Zacny VL; Smith JF; Johnston RE Virology; 1995 Sep; 212(1):102-10. PubMed ID: 7676619 [TBL] [Abstract][Full Text] [Related]
12. A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis. Davis NL; Grieder FB; Smith JF; Greenwald GF; Valenski ML; Sellon DC; Charles PC; Johnston RE Arch Virol Suppl; 1994; 9():99-109. PubMed ID: 8032286 [TBL] [Abstract][Full Text] [Related]
13. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus. Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514 [TBL] [Abstract][Full Text] [Related]
14. Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Johnson BJ; Brubaker JR; Roehrig JT; Trent DW Virology; 1990 Aug; 177(2):676-83. PubMed ID: 1695412 [TBL] [Abstract][Full Text] [Related]
15. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies. Rosas CT; Paessler S; Ni H; Osterrieder N Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789 [TBL] [Abstract][Full Text] [Related]
16. Improved method for production of attenuated Venezuelan equine encephalomyelitis (TC-83 strain) vaccine. Cole FE; Pedersen CE; Robinson DM; Eddy GA J Clin Microbiol; 1976 Apr; 3(4):460-2. PubMed ID: 1262457 [TBL] [Abstract][Full Text] [Related]
17. Effect of back passage of Venezuelan equine encephalomyelitis TC-83 vaccine virus on clinical, virologic, and immune responses in horses. Luedke AJ; Barber TL; Foster NM; Batalla D; Mercado S J Am Vet Med Assoc; 1972 Oct; 161(7):824-31. PubMed ID: 5074264 [No Abstract] [Full Text] [Related]
19. [The postvaccinal reaction in hamadryas baboons to the administration of attenuated strain 15 of the Venezuelan equine encephalomyelitis virus]. Filatenkov AG; Khaltaeva GG; Lukin EP; Gorban' SG; Khamitova MF; Shkurnikova NN Biull Eksp Biol Med; 1991 Mar; 111(3):287-90. PubMed ID: 2054507 [TBL] [Abstract][Full Text] [Related]
20. Differential accumulation of genetic and phenotypic changes in Venezuelan equine encephalitis virus and Japanese encephalitis virus following passage in vitro and in vivo. McCurdy K; Joyce J; Hamilton S; Nevins C; Sosna W; Puricelli K; Rayner JO Virology; 2011 Jun; 415(1):20-9. PubMed ID: 21507450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]